Neuroimaging anomalies in asymptomatic middle cerebral artery steno-occlusive disease with normal-appearing white matter.
cortical thickness
diffusion tensor imaging
functional connectivity
functional magnetic resonance imaging
middle cerebral artery
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
05
2023
accepted:
31
07
2023
medline:
11
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Asymptomatic chronic cerebrovascular steno-occlusive disease is common, but the cognitive function and alterations in the brain's structural and functional profiles have not been well studied. This study aimed to reveal whether and how patients with asymptomatic middle cerebral artery (MCA) steno-occlusive disease and normal-appearing white matter differ in brain structural and functional profiles from normal controls and their correlations with cognitive function. In all, 26 patients with asymptomatic MCA steno-occlusive disease and 22 healthy controls were compared for neurobehavioral assessments, brain volume, cortical thickness, fiber connectivity density (FiCD) value, and resting-state functional connectivity (FC) using multimodal MRI. We also investigated the associations between abnormal cortical thicknesses, FiCD values, and functional connectivities with the neurobehavioral assessments. Patients performed worse on memory tasks (Auditory Verbal Learning Test-Huashan version) compared with healthy controls. Patients were divided into two groups: the right group (patients with right MCA steno-occlusive disease) and the left group (patients with left MCA steno-occlusive disease). The left group showed significant cortical thinning in the left superior parietal lobule, while the right group showed significant cortical thinning in the right superior parietal lobule and caudal portion of the right middle frontal gyrus. Increased FiCD values in the superior frontal region of the left hemisphere were observed in the left group. In addition, a set of interhemispheric and intrahemispheric FC showed a significant decrease or increase in both the left and right groups. Many functional connectivity profiles were positively correlated with cognitive scores. No correlation was found between cortical thickness, FiCD values, and cognitive scores. Even if the patients with MCA steno-occlusive disease were asymptomatic and had normal-appearing white matter, their cognitive function and structural and functional profiles had changed, especially the FC. Alterations in FC may be an important mechanism underlying the neurodegenerative process in patients with asymptomatic MCA steno-occlusive disease before structural changes occur, so FC assessment may promote the detection of network alterations, which may be used as a biomarker of disease progression and therapeutic efficacy evaluation in these patients.
Sections du résumé
Background
UNASSIGNED
Asymptomatic chronic cerebrovascular steno-occlusive disease is common, but the cognitive function and alterations in the brain's structural and functional profiles have not been well studied. This study aimed to reveal whether and how patients with asymptomatic middle cerebral artery (MCA) steno-occlusive disease and normal-appearing white matter differ in brain structural and functional profiles from normal controls and their correlations with cognitive function.
Methods
UNASSIGNED
In all, 26 patients with asymptomatic MCA steno-occlusive disease and 22 healthy controls were compared for neurobehavioral assessments, brain volume, cortical thickness, fiber connectivity density (FiCD) value, and resting-state functional connectivity (FC) using multimodal MRI. We also investigated the associations between abnormal cortical thicknesses, FiCD values, and functional connectivities with the neurobehavioral assessments.
Results
UNASSIGNED
Patients performed worse on memory tasks (Auditory Verbal Learning Test-Huashan version) compared with healthy controls. Patients were divided into two groups: the right group (patients with right MCA steno-occlusive disease) and the left group (patients with left MCA steno-occlusive disease). The left group showed significant cortical thinning in the left superior parietal lobule, while the right group showed significant cortical thinning in the right superior parietal lobule and caudal portion of the right middle frontal gyrus. Increased FiCD values in the superior frontal region of the left hemisphere were observed in the left group. In addition, a set of interhemispheric and intrahemispheric FC showed a significant decrease or increase in both the left and right groups. Many functional connectivity profiles were positively correlated with cognitive scores. No correlation was found between cortical thickness, FiCD values, and cognitive scores.
Conclusion
UNASSIGNED
Even if the patients with MCA steno-occlusive disease were asymptomatic and had normal-appearing white matter, their cognitive function and structural and functional profiles had changed, especially the FC. Alterations in FC may be an important mechanism underlying the neurodegenerative process in patients with asymptomatic MCA steno-occlusive disease before structural changes occur, so FC assessment may promote the detection of network alterations, which may be used as a biomarker of disease progression and therapeutic efficacy evaluation in these patients.
Identifiants
pubmed: 37693758
doi: 10.3389/fneur.2023.1206786
pmc: PMC10484479
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1206786Informations de copyright
Copyright © 2023 Huang, Xia, Guan, Gong, Luo, Shi, Zhang and Meng.
Déclaration de conflit d'intérêts
LS is the director of BrainNow Medical Technology Limited and YL is now employed by BrainNow Medical Technology Limited. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Public Health. 2021 Sep;198:75-81
pubmed: 34365109
Acta Radiol. 2019 Jun;60(6):769-776
pubmed: 30185071
AJNR Am J Neuroradiol. 2004 Apr;25(4):558-64
pubmed: 15090341
J Neuroinflammation. 2020 Jan 3;17(1):2
pubmed: 31900229
BMC Cardiovasc Disord. 2019 Jun 25;19(1):154
pubmed: 31238977
Clin Sci (Lond). 2017 Sep 28;131(19):2451-2468
pubmed: 28963120
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Front Psychol. 2016 May 30;7:809
pubmed: 27303358
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
PLoS One. 2012;7(12):e51157
pubmed: 23236445
PLoS One. 2017 Dec 14;12(12):e0189727
pubmed: 29240808
Acta Radiol. 2007 Apr;48(3):335-40
pubmed: 17453507
Front Neurol. 2020 Apr 15;11:214
pubmed: 32351440
Nat Rev Neurosci. 2014 Oct;15(10):683-95
pubmed: 25186238
J Magn Reson Imaging. 1998 Jul-Aug;8(4):767-74
pubmed: 9702876
J Cereb Blood Flow Metab. 2019 Nov;39(11):2132-2143
pubmed: 29968499
Neural Plast. 2017;2017:8738714
pubmed: 28255464
Neural Plast. 2020 Sep 23;2020:9345602
pubmed: 33029129
BMC Psychiatry. 2021 Oct 4;21(1):485
pubmed: 34607584
J Cereb Blood Flow Metab. 2015 Feb;35(2):240-7
pubmed: 25388676
J Vasc Surg. 2021 May;73(5):1611-1621.e2
pubmed: 33166609
Brain Imaging Behav. 2022 Jun;16(3):1314-1323
pubmed: 35000065
Lancet Neurol. 2011 Sep;10(9):829-43
pubmed: 21778116
Neuroscience. 2017 Mar 6;344:15-24
pubmed: 28039039
J Cereb Blood Flow Metab. 2020 Feb;40(2):314-327
pubmed: 30480463
Front Neurosci. 2020 Feb 12;14:83
pubmed: 32116526
Eur J Neurol. 2020 Jun;27(6):1062-1065
pubmed: 32157762
Clin Radiol. 2013 Aug;68(8):815-22
pubmed: 23623577
Neuroimage Clin. 2019;24:102101
pubmed: 31835289
Ann Transl Med. 2022 Sep;10(18):1003
pubmed: 36267716
Neurology. 2004 Mar 9;62(5):695-701
pubmed: 15007116
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Neuroscience. 2021 Jul 15;467:16-27
pubmed: 34022325
BMC Neurol. 2021 Sep 13;21(1):350
pubmed: 34517833
Stroke. 2012 Oct;43(10):2567-73
pubmed: 22935402
J Cereb Blood Flow Metab. 2021 Feb;41(2):380-396
pubmed: 32237952
PLoS One. 2014 Jan 15;9(1):e85441
pubmed: 24454868
Front Aging Neurosci. 2021 Jul 05;13:620763
pubmed: 34295237
Neuroimage Clin. 2016 Sep 19;12:640-644
pubmed: 27722088
Clin Interv Aging. 2020 Nov 06;15:2083-2094
pubmed: 33192055
BMC Neurol. 2019 Jul 5;19(1):151
pubmed: 31277587
Neuroimage Clin. 2018 Aug 09;20:476-484
pubmed: 30128286
Int J Stroke. 2015 Dec;10(8):1197-203
pubmed: 26235564
Ann Neurol. 2011 Aug;70(2):237-44
pubmed: 21674583
Neuroimage. 1999 Feb;9(2):195-207
pubmed: 9931269
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573